These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19564249)

  • 1. Gq-initiated cardiomyocyte hypertrophy is mediated by phospholipase Cbeta1b.
    Filtz TM; Grubb DR; McLeod-Dryden TJ; Luo J; Woodcock EA
    FASEB J; 2009 Oct; 23(10):3564-70. PubMed ID: 19564249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phospholipase Cbeta1b associates with a Shank3 complex at the cardiac sarcolemma.
    Grubb DR; Iliades P; Cooley N; Yu YL; Luo J; Filtz TM; Woodcock EA
    FASEB J; 2011 Mar; 25(3):1040-7. PubMed ID: 21148417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The extreme C-terminal region of phospholipase Cbeta1 determines subcellular localization and function; the "b" splice variant mediates alpha1-adrenergic receptor responses in cardiomyocytes.
    Grubb DR; Vasilevski O; Huynh H; Woodcock EA
    FASEB J; 2008 Aug; 22(8):2768-74. PubMed ID: 18390926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective activation of the "b" splice variant of phospholipase Cbeta1 in chronically dilated human and mouse atria.
    Woodcock EA; Grubb DR; Filtz TM; Marasco S; Luo J; McLeod-Dryden TJ; Kaye DM; Sadoshima J; Du XJ; Wong C; McMullen JR; Dart AM
    J Mol Cell Cardiol; 2009 Nov; 47(5):676-83. PubMed ID: 19729020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The phosphatidylinositol(4,5)bisphosphate-binding sequence of transient receptor potential channel canonical 4α is critical for its contribution to cardiomyocyte hypertrophy.
    Cooley N; Grubb DR; Luo J; Woodcock EA
    Mol Pharmacol; 2014 Oct; 86(4):399-405. PubMed ID: 25049082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scaffolding protein Homer 1c mediates hypertrophic responses downstream of Gq in cardiomyocytes.
    Grubb DR; Luo J; Yu YL; Woodcock EA
    FASEB J; 2012 Feb; 26(2):596-603. PubMed ID: 22012123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential treatment of cardiac hypertrophy and heart failure by inhibiting the sarcolemmal binding of phospholipase Cbeta1b.
    Woodcock EA; Grubb DR; Iliades P
    Curr Drug Targets; 2010 Aug; 11(8):1032-40. PubMed ID: 20426766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RGS2 inhibits beta-adrenergic receptor-induced cardiomyocyte hypertrophy.
    Nunn C; Zou MX; Sobiesiak AJ; Roy AA; Kirshenbaum LA; Chidiac P
    Cell Signal; 2010 Aug; 22(8):1231-9. PubMed ID: 20362664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phospholipase Cβ1b directly binds the SH3 domain of Shank3 for targeting and activation in cardiomyocytes.
    Grubb DR; Luo J; Woodcock EA
    Biochem Biophys Res Commun; 2015 Jun; 461(3):519-24. PubMed ID: 25911318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcellular compartmentalization of proximal Gα
    Dahl EF; Wu SC; Healy CL; Harsch BA; Shearer GC; O'Connell TD
    J Biol Chem; 2018 Jun; 293(23):8734-8749. PubMed ID: 29610273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G-proteins in growth and apoptosis: lessons from the heart.
    Adams JW; Brown JH
    Oncogene; 2001 Mar; 20(13):1626-34. PubMed ID: 11313910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II induced upregulation of G alpha q/11, phospholipase C beta 3 and extracellular signal-regulated kinase 1/2 via angiotensin II type 1 receptor.
    Bai H; Wu LL; Xing DQ; Liu J; Zhao YL
    Chin Med J (Engl); 2004 Jan; 117(1):88-93. PubMed ID: 14733781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac-specific overexpression of diacylglycerol kinase zeta prevents Gq protein-coupled receptor agonist-induced cardiac hypertrophy in transgenic mice.
    Arimoto T; Takeishi Y; Takahashi H; Shishido T; Niizeki T; Koyama Y; Shiga R; Nozaki N; Nakajima O; Nishimaru K; Abe J; Endoh M; Walsh RA; Goto K; Kubota I
    Circulation; 2006 Jan; 113(1):60-6. PubMed ID: 16380548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ins(1,4,5)P(3) regulates phospholipase Cbeta1 expression in cardiomyocytes.
    Vasilevski O; Grubb DR; Filtz TM; Yang S; McLeod-Dryden TJ; Luo J; Karna D; Chen J; Woodcock EA
    J Mol Cell Cardiol; 2008 Nov; 45(5):679-84. PubMed ID: 18692062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenergic pathways and left ventricular remodeling.
    Dorn GW
    J Card Fail; 2002 Dec; 8(6 Suppl):S370-3. PubMed ID: 12555147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-mediated overexpression of diacylglycerol kinase-zeta inhibits endothelin-1-induced cardiomyocyte hypertrophy.
    Takahashi H; Takeishi Y; Seidler T; Arimoto T; Akiyama H; Hozumi Y; Koyama Y; Shishido T; Tsunoda Y; Niizeki T; Nozaki N; Abe J; Hasenfuss G; Goto K; Kubota I
    Circulation; 2005 Mar; 111(12):1510-6. PubMed ID: 15781737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross talk between corticosteroids and alpha-adrenergic signalling augments cardiomyocyte hypertrophy: a possible role for SGK1.
    Lister K; Autelitano DJ; Jenkins A; Hannan RD; Sheppard KE
    Cardiovasc Res; 2006 Jun; 70(3):555-65. PubMed ID: 16533503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galphaq expression activates EGFR and induces Akt mediated cardiomyocyte survival: dissociation from Galphaq mediated hypertrophy.
    Howes AL; Miyamoto S; Adams JW; Woodcock EA; Brown JH
    J Mol Cell Cardiol; 2006 May; 40(5):597-604. PubMed ID: 16466740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IGF-II/mannose-6-phosphate receptor signaling induced cell hypertrophy and atrial natriuretic peptide/BNP expression via Galphaq interaction and protein kinase C-alpha/CaMKII activation in H9c2 cardiomyoblast cells.
    Chu CH; Tzang BS; Chen LM; Kuo CH; Cheng YC; Chen LY; Tsai FJ; Tsai CH; Kuo WW; Huang CY
    J Endocrinol; 2008 May; 197(2):381-90. PubMed ID: 18434368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Galphaq/Galpha11 in cardiomyocytes.
    Wettschureck N; Rütten H; Zywietz A; Gehring D; Wilkie TM; Chen J; Chien KR; Offermanns S
    Nat Med; 2001 Nov; 7(11):1236-40. PubMed ID: 11689889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.